Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Change in Accured Expenses (2022 - 2023)

Historic Change in Accured Expenses for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to -$2.1 million.

  • Lexeo Therapeutics' Change in Accured Expenses fell 13348.02% to -$2.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $3.4 million for FY2024, which is 6102.34% up from last year.
  • Latest data reveals that Lexeo Therapeutics reported Change in Accured Expenses of -$2.1 million as of Q4 2023, which was down 13348.02% from $4.8 million recorded in Q3 2023.
  • Lexeo Therapeutics' Change in Accured Expenses' 5-year high stood at $4.8 million during Q3 2023, with a 5-year trough of -$2.1 million in Q4 2023.